Trusted Resource for Clinical Trials, Protocols & Progress
CRO partnerships affect nearly every function involved in clinical development. A single-point decision can overlook critical risks or opportunities. Involving cross-functional teams ensures:
Click to read the full article.
Sponsor responsibilities do not end with outsourcing. Regulatory guidelines emphasize that:
Click to read the full article.
Sponsor personnel must understand their roles in CRO oversight to:
Click to read the full article.
According to USFDA and EMA regulations, failure to follow the trial protocol is a significant compliance violation. Common consequences include:
Click to read the full article.
Unlike single-CRO models, multi-vendor trials pose unique challenges:
Click to read the full article.
As per USFDA and CDSCO expectations, sponsors retain ultimate responsibility for trial conduct—even when services are outsourced. Poor dispute handling can lead to protocol deviations, loss of trust, or regulatory findings. Effective escalation systems help:
Click to read the full article.
Audit readiness refers to the ability of a CRO to demonstrate compliance with GCP guidelines, protocol requirements, and contractual obligations at any point during or after a clinical trial. It includes maintaining complete documentation, ensuring trained staff, and being prepared for both announced and unannounced inspections.
Click to read the full article.
Real-time communication enhances:
Click to read the full article.
Outsourcing key trial activities means sponsors must rely on CROs for regulatory compliance, subject safety, and data quality. Without trust:
Click to read the full article.
Monitoring metrics provides sponsors with:
Click to read the full article.
